Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-10-19 Sale |
2022-10-21 9:30 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
600,000 | $8.45 | $5,070,000 | 19,607,546 (Indirect Direct) |
View |
2022-09-29 Sale |
2022-09-30 4:05 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
400,000 | $7.3523 | $2,940,920 | 20,207,546 (Indirect Direct) |
View |
2022-07-21 Sale |
2022-07-21 7:13 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
4,227 | $5.3295 | $22,528 | 17,353,750 (Indirect Direct) |
View |
2022-06-08 Sale |
2022-06-10 7:51 pm |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
29,615 | $20.17 | $597,214 | 494,077 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 4:05 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
65,725 | $3.6684 | $241,106 | 17,357,977 (Indirect Direct) |
View |
2022-04-21 Sale |
2022-04-22 08:31 am |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
4,227 | $5.87 | $24,812 | 17,423,702 (Indirect Direct) |
View |
2022-03-10 Sale |
2022-03-11 7:14 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
65,725 | $7.4835 | $491,850 | 17,427,929 (Indirect Direct) |
View |
2022-01-24 Sale |
2022-01-25 4:15 pm |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
17,100 | $8.0052 | $136,889 | 17,493,654 (Indirect Direct) |
View |
2021-12-20 Sale |
2021-12-22 7:59 pm |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
50,000 | $43.57 | $2,178,500 | 151,721 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-10 Option Award |
2025-04-11 4:41 pm |
N/A 2035-04-09 |
Kalaris Therapeutics Inc. | KLRS | Hallal David Director |
18,000 | $0 | 18,000 (Direct) |
View |
2024-06-27 Option Award |
2024-07-01 5:12 pm |
N/A 2034-06-27 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
31,500 | $0 | 322,095 (Direct) |
View |
2024-06-12 Option Award |
2024-06-14 4:19 pm |
N/A N/A |
Seer Inc. | SEER | Hallal David Director |
58,178 | $0 | 355,128 (Direct) |
View |
2024-06-11 Option Award |
2024-06-13 8:00 pm |
2025-06-11 2034-06-11 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
24,200 | $0 | 24,200 (Direct) |
View |
2024-06-06 Option Award |
2024-06-07 4:05 pm |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
35,000 | $0 | 19,677,546 (Direct) |
View |
2023-06-21 Option Award |
2023-06-22 6:47 pm |
N/A 2033-06-21 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
36,000 | $0 | 36,000 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 9:16 pm |
N/A 2033-06-14 |
Seer Inc. | SEER | Hallal David Director |
58,178 | $0 | 331,685 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 7:54 pm |
2024-06-13 2033-06-13 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
22,383 | $0 | 22,383 (Direct) |
View |
2023-05-11 Option Award |
2023-05-12 5:00 pm |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
35,000 | $0 | 19,642,546 (Direct) |
View |
2022-07-28 Option Award |
2022-08-01 4:38 pm |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
3,253,796 | $4.61 | 20,607,546 (Indirect) |
View |
2022-06-16 Option Award |
2022-06-21 5:01 pm |
N/A 2032-06-16 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
14,000 | $0 | 14,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 6:36 pm |
N/A 2031-06-15 |
Seer Inc. | SEER | Hallal David Director |
39,585 | $0 | 303,147 (Direct) |
View |
2022-06-08 Exercise |
2022-06-10 7:51 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
11,899 | $2.95 | 494,077 (Direct) |
View |
2022-06-08 Exercise |
2022-06-10 7:51 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
17,716 | $4.23 | 494,077 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 7:51 pm |
N/A 2032-06-09 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
17,538 | $0 | 494,077 (Direct) |
View |
2022-06-08 Exercise |
2022-06-10 7:51 pm |
N/A 2030-05-01 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
29,615 | $0 | 494,077 (Direct) |
View |
2022-05-26 Option Award |
2022-05-27 4:34 pm |
N/A 2032-05-26 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
28,000 | $0 | 28,000 (Direct) |
View |
2022-05-17 Option Award |
2022-05-19 4:24 pm |
N/A 2032-05-16 |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
27,500 | $0 | 27,500 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 7:59 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
20,000 | $4.3 | 151,721 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 7:59 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
30,000 | $2.95 | 151,721 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 7:59 pm |
N/A 2025-06-11 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
50,000 | $0 | 151,721 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 6:28 pm |
N/A 2031-06-17 |
Seer Inc. | SEER | Hallal David Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-21 8:13 pm |
N/A 2031-06-17 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
16,608 | $0 | 16,608 (Direct) |
View |
2021-05-27 Option Award |
2021-06-01 4:17 pm |
N/A 2031-05-27 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
7,800 | $0 | 7,800 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 4:54 pm |
N/A 2031-05-24 |
Allovir Inc. | ALVR | Hallal David Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
2021-01-21 Option Award |
2021-01-25 5:04 pm |
N/A 2031-01-21 |
Allovir Inc. | ALVR | Hallal David Chief Executive Officer 10% Owner |
420,000 | $0 | 17,783,754 (Direct) |
View |
2020-12-03 Option Award |
2020-12-11 9:11 pm |
N/A 2020-12-03 |
Seer Inc. | SEER | Hallal David Director |
18,691 | $0 | 18,691 (Direct) |
View |
Ownership |
2020-12-03 7:51 pm |
N/A N/A |
Seer Inc. | SEER | Hallal David Director |
0 | $0 | 455,623 (Direct) |
View |
2020-07-23 Option Award(A) |
2020-10-21 4:56 pm |
N/A 2030-07-23 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
16,608 | $0 | 0 (Direct) |
View |
2020-08-03 Conversion |
2020-08-05 9:56 pm |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Chief Executive Officer 10% Owner |
35,649,033 | $0 | 2,821,819 (Indirect) |
View |
2020-07-29 Option Award |
2020-07-31 6:46 pm |
N/A 2030-07-29 |
Allovir Inc. | ALVR | Hallal David Chief Executive Officer 10% Owner |
1,101,000 | $0 | 1,101,000 (Direct) |
View |
Ownership |
2020-07-30 08:22 am |
N/A N/A |
Allovir Inc. | ALVR | Hallal David Chief Executive Officer 10% Owner |
0 | $0 | 17,363,754 (Direct) |
View |
2020-07-23 Option Award |
2020-07-24 7:23 pm |
N/A 2030-07-23 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
16,608 | $0 | 0 (Direct) |
View |
Ownership |
2020-07-23 7:30 pm |
N/A 2025-06-11 |
iTeos Therapeutics Inc. | ITOS | Hallal David Director |
0 | $0 | 231,050 (Direct) |
View |
2020-06-16 Option Award |
2020-06-18 4:32 pm |
N/A 2030-06-16 |
Scholar Rock Holding Corp | SRRK | Hallal David Director |
20,000 | $0 | 20,000 (Direct) |
View |